Mesothelioma Environmental Risk Factors and Epidemiological and Biological Insights
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 10 August 2026 | Viewed by 677
Special Issue Editor
Special Issue Information
Dear Colleagues,
Mesothelioma is a malignant tumor of serosal membranes with protean morphology and complex biology that has long been regarded as a signal tumor for exposure to asbestos. It typically has a poor prognosis, and treatment options remain limited. Owing to a long latency between asbestos exposure and tumor development, case numbers worldwide are expected to remain high for years to come, despite bans on asbestos in many countries. The role of genetic disease predisposition continues to be explored. Personalized and targeted therapy for mesothelioma is in its infancy. Molecular characterization of mesothelial lesions is leading to improved tumor classification, and as our molecular understanding of mesothelial lesions deepens, therapeutic options expand. This Special Issue will explore the global burden of disease, along with factors impacting disease development and all basic and clinical aspects of therapy that advance our understanding, diagnosis and treatment of mesothelial lesions.
Dr. Sonja Klebe
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesothelioma
- asbestos
- mesothelial proliferation
- therapy
- marker
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
